NCT05894122View on ClinicalTrials.gov

Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®)

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

December 13, 2023

Primary Completion Date

December 12, 2025

Study Completion Date

December 12, 2025

Conditions
PhenylketonuriaMetabolic Diseases
Interventions
DIAGNOSTIC_TEST

DM-DIV MITRA®

Comparison of phenylalanine concentrations in the new device with those in the current device (blotter).

Trial Locations (1)

38043

RECRUITING

CHU Grenoble Alpes, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT05894122 - Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®) | Biotech Hunter | Biotech Hunter